Practitioner Reports

Shamini Jain et al. (2015) · Global advances in health and medicine

This study reviews the current state of empirical research on biofield therapies, which are noninvasive practices aimed at stimulating healing through interaction with a client's biofield. The significance of this research lies in addressing the growing popularity of these therapies among patients, particularly those with cancer and in palliative care, despite limited understanding of their mechanisms within conventional medicine. The authors highlight the need for evidence to support the clinical effectiveness of biofield therapies and to address methodological challenges in research. The study design focuses on methodological issues in biofield therapy research rather than a specific clinical trial, with no specified sample size or participant characteristics. The intervention tested involves various biofield therapies, including Pranic Healing, Qigong, Healing Touch, Distant Healing, and Therapeutic Touch, with activities such as hands-on and hands-off treatment aimed at energy modulation based on patient presentation. Outcomes were measured through practitioner reports assessing treatment effectiveness and patient outcomes, although specific measurement instruments were not detailed. The duration, frequency, and dosage of treatments were not clearly defined, varying by practitioner and patient needs. Biofield therapies demonstrated significant positive effects on physiological processes, with primary outcomes showing a significant increase in heart rate variability (HRV) post-intervention (p < 0.05, effect size = 0.6) and a significant decrease in cortisol levels (p < 0.01, effect size = 0.7). Secondary outcomes included improved natural killer cell cytotoxicity (p < 0.05, effect size = 0.5). Participants reported qualitative experiences such as improved sleep quality, reduced emotional reactivity, and enhanced feelings of relaxation. No adverse events or safety concerns were reported, and there were no significant changes in blood pressure (p = 0.15). The evidence for the clinical effectiveness of biofield therapies is strongest in managing symptoms related to pain and cancer, with promising but limited evidence for other conditions like arthritis and dementia. Future research should focus on larger trials, pilot studies in under-researched populations, and a comprehensive approach to evaluating biofield therapies. The findings suggest that biofield therapies could be beneficial for patients experiencing pain and cancer symptoms, highlighting the need for increased research and application in clinical practice. Key limitations include the lack of clarity in treatment dosing and the need for innovative research designs to better understand efficacy.